Wolff C, 1982-05: German case report claiming the first human use of fenbendazole, in a patient with visceral larva migrans, reported as highly effective; the abstract gives no dose.
The application of Fenbendazole for the first time in humans showed to be highly effective against this ubiquitous illness.
Abstract
Wolff C, 1982-05: German case report claiming the first human use of fenbendazole, in a patient with visceral larva migrans, reported as highly effective; the abstract gives no dose. Study type: single case report, n=1, Germany (author's translation of the German title). Dose, schedule and duration: not stated in the abstract captured. Route oral. Other treatment: none stated. Outcome: clinical and laboratory resolution as described by the author. Funder and conflicts: not stated. Comparator: none. Bearing basis: earliest indexed claim of therapeutic fenbendazole use in a human; the abstract's claim of 'first time in humans' sits awkwardly with the 1976 and 1977 trials in the same record, and that discrepancy is recorded rather than resolved. Study type: case report.
